Description
Cortagen is a short tetrapeptide bioregulator studied primarily for its activity in central nervous system research models. Experimental findings suggest tissue-preferential effects in neural and peripheral nerve tissues, with additional observations in cardiac and immune-related systems. Cortagen has been investigated for its influence on inflammatory signaling balance and oxidative-stress regulation within neural environments.
In preclinical studies, the peptide has been evaluated for its effects on gene-expression modulation, chromatin structure dynamics, and cytokine-related signaling, including interleukin-2 expression in immune-cell models. Research also explores its role in oxidative processes and neuroinflammatory balance following experimental ischemic or injury-related models. All findings are investigational and limited to in-vitro and preclinical laboratory research contexts.
For research use only. Not for human consumption.
References:
Khavinson VK et al., Neurochem J, 2006 142(1):76–79
Trofimova SV et al., Adv Gerontol, 2015 28(3):432–439
Sokolova IB et al., Bull Exp Biol Med, 2014;157(6):772–775
Reviews
There are no reviews yet.